Get the content you want anytime you want.
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.


The Top 10 Things Infection Preventionists Want for the Holidays
Here are a few things your friendly infection control team would appreciate for the holidays.
Valley Fever Rapid Diagnostic Test Approved by FDA
The US Food and Drug Administration (FDA) has approved a rapid diagnostic test for Valley Fever.
NIH & WHO Experts Warn of Severe Flu Season in the United States
Following a severe flu season in the Southern Hemisphere and mounting research that egg-based flu vaccines don’t offer enough protection, experts are warning that the Northern Hemisphere may be in for a tough flu season.
Top 5 Infectious Disease News for November 2017
We break down the Top 5 infectious disease news reported by Contagion® for the month of November 2017.
NIAID's Zika Vaccine Yields Positive Results in Human Studies
The results of 3 phase 1 clinical trials have shown that an investigational Zika purified inactivated virus vaccine was well-tolerated and induced an immune response in adult participants.
Treatments for Multidrug-Resistant Infections May Be Found in Other FDA-Approved Drugs
This approach could significantly cut down on the cost and time needed to develop new antibiotics, which is critical considering the current antibiotic landscape.
Top 5 <i>Contagion</i>® News Articles for the Week of November 26, 2017
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
NIH Announces First Trial Assessing Safety of Injectable HIV PrEP in Women
The National Institutes of Health (NIH) have announced plans for a new trial testing the effectiveness of the injectable pre-exposure prophylaxis (PrEP) drug, cabotegravir, in sexually-active women.
We break down our top HIV news stories of 2017. Did you read them all?